OCT Biomarkers for Diabetic Retinopathy

Active, not recruitingOBSERVATIONAL

Enrollment

165

Participants

Timeline

Start Date

January 26, 2015

Primary Completion Date

February 24, 2020

Study Completion Date

December 31, 2026

Conditions

Diabetic Retinopathy

Trial Locations (1)

Oregon Health & Science University, Portland

All Listed Sponsors

lead

Oregon Health and Science University

OTHER

NCT02330042 - OCT Biomarkers for Diabetic Retinopathy | Biotech Hunter | Biotech Hunter